Glucocorticoid receptor (GR) agonism has potent anti-inflammatory effects and GR agonists have been used as rheumatoid arthritis therapies, though undesired side effects remain in many patients 72-74. The gene discussed is NR3C1; the disease is rheumatoid arthritis.